Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Passes Baton: Former Zimmer Chief To Replace Tobin

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific's newly appointed CEO Ray Elliott brings a reputation as a cost-cutter with a focus on profitability from his decade-long experience as chief exec at orthopedic firm Zimmer
Advertisement

Related Content

Ray Elliott Retiring: Is Boston Scientific On Or Off Track?
Ray Elliott Retiring: Is Boston Scientific On Or Off Track?
Boston Scientific Recalls All Implantable Defibrillators, Suspends Sales
Boston Scientific Recalls All Implantable Defibrillators, Suspends Sales
With Restructuring, Ray Elliott Makes Boston Scientific His Own
Boston Scientific Settles More Stent Patent Suits With J&J, For $1.7 Billion
Elliott Makes Marketing Infrastructure A Priority At Boston Scientific
Ortho Earnings: Stryker Plans Big Compliance Investment In 2009
Execs Make Moves: Zimmer Gets New Chief, Best Leaves Boston Sci
Execs Make Moves: Zimmer Gets New Chief, Best Leaves Boston Sci

Topics

Advertisement
UsernamePublicRestriction

Register

MT027590

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel